3-(4-HYDROXY-2,3-DIMETHYL-PHENYL)-PROPIONIC ACID ETHYL ESTER, 95.0%, 5g

4,6-Dimethylisothiazolo[5,4-b]pyridin-3-amine, 95.0%, 5g

3-Bromo-4-fluoroaniline hydrochloride, 95.0%, 25g

Hexadecyltrimethylammonium Perchlorate>98.0%(N)1g

(tert-Butoxycarbonyl)-L-alanyl-L-alanine>98.0%(HPLC)5g

ethyl (1R,5S,6R)-2-oxobicyclo[3.1.0]hexane-6-carboxylate, 97%, 25mg

tert-Butyl vinyl ether, 98.0%, 25g

2-Bromo-6-chloroanisole, 95.0%, 5g

GC capillary column ROTI®Cap-5, 30 m, 0.25 mm, 0.50 µm, 1 Piece(s)

Ethyl 1-(5-(trifluoromethyl)pyridin-2-yl)piperidine-4-carboxylate, 5g

5-(difluoromethyl)-1,3,4-thiadiazol-2-amine, 95+%, 50g

4-Amino-5-bromo-2-chloropyrimidine, 95.0%, 25g

4,4,5,5-TETRAMETHYL-2-(1-PHENYLCYCLOPROPYL)-1,3,2-DIOXABOROLANE, 95.0%, 250mg